These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21545002)

  • 1. [Foeto-maternal haemorrhage--detection and quantification].
    Gielezyńska A; Fabijańska-Mitek J
    Pol Merkur Lekarski; 2011 Mar; 30(177):219-23. PubMed ID: 21545002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calculation of feto-maternal haemorrhage volume using various morphological parameters and various formulas].
    Gielezynska A; Fabijańska-Mitek J; Debska M
    Pol Merkur Lekarski; 2011 Mar; 30(177):228-30. PubMed ID: 21545004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two techniques for the evaluation of fetomaternal hemorrhage in RhD-negative women: gel agglutination and haemoglobin F determination by flow cytometry.
    Ben-Haroush A; Belkin A; Chezar J; Orlin J; Hod M; Bar J
    Acta Obstet Gynecol Scand; 2007; 86(7):821-6. PubMed ID: 17611827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal-maternal hemorrhage detection in Ontario.
    Lafferty JD; Raby A; Crawford L; Linkins LA; Richardson H; Crowther M
    Am J Clin Pathol; 2003 Jan; 119(1):72-7. PubMed ID: 12520700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.
    Post GR; Lazarchick J; Singh ZN
    Lab Hematol; 2012 Jun; 18(2):11-3. PubMed ID: 22709788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis.
    Kumpel B; Hazell M; Guest A; Dixey J; Mushens R; Bishop D; Wreford-Bush T; Lee E
    Transfusion; 2014 May; 54(5):1305-16. PubMed ID: 24236535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scientific basis of antenatal prophylaxis.
    Urbaniak SJ
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytometric quantitation of foeto-maternal haemorrhage with the Abbott Cell-Dyn CD4000 haematology analyser.
    Little BH; Robson R; Roemer B; Scott CS
    Clin Lab Haematol; 2005 Feb; 27(1):21-31. PubMed ID: 15686504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feto - maternal haemorrhage in parturients: Incidence and its determinants.
    Adeniji AO; Mabayoje VO; Raji AA; Muhibi MA; Tijani AA; Adeyemi AS
    J Obstet Gynaecol; 2008 Jan; 28(1):60-3. PubMed ID: 18259901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guideline for prevention of RhD alloimmunization in RhD negative women].
    Lubuský M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2010 Aug; 75(4):323-4. PubMed ID: 20925231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
    Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
    Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative fetomaternal hemorrhage assessment with the use of five laboratory tests.
    Gielezynska A; Stachurska A; Fabijanska-Mitek J; Debska M; Muzyka K; Kraszewska E
    Int J Lab Hematol; 2016 Aug; 38(4):419-25. PubMed ID: 27320948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow Cytometry in Detection of Fetal Red Blood Cells and Maternal F Cells to Identify Fetomaternal Hemorrhage.
    Farias MG; Dal Bó S; Castro SM; da Silva AR; Bonazzoni J; Scotti L; Costa SH
    Fetal Pediatr Pathol; 2016; 35(6):385-391. PubMed ID: 27494244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D.
    Radel DJ; Penz CS; Dietz AB; Gastineau DA
    Transfusion; 2008 Sep; 48(9):1886-91. PubMed ID: 18513253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.